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ABSTRACT 
GH12C1, a clonal strain of rat pituitary tumor cells in culture (GH cells), does not 
produce detectable amounts of prolactin.  5-Bromodeoxyuridine (BrdUrd), the 
thymidine analogue,  at  sublethal concentrations (3-5  /xg/ml)  induces prolactin 
synthesis in these cells. BrdUrd also induces prolactin synthesis in F1BGH12C1 
cells, a BrdUrd resistant (BrdUrd  r) substrain isolated from GH12C1 cells. The 
F1BGH~2C1 strain is not drug dependent, but its resistance to BrdUrd is a stable 
phenotype. The significant features of the induction of prolactin synthesis in the 
BrdUrd  r strain are the increased net synthesis of prolactin and the shortening of 
the lag period of prolactin induction. As BrdUrd concentration in the growth 
medium  is  increased,  the  rise  in  prolactin  synthesis  parallels  the  increased 
incorporation of BrdUrd into DNA.  Prolactin synthesis is first detected when 
BrdUrd replaces 20-25%  of the thymidine in DNA. BrdUrd can replace up to 
75-80% of the thymidine within 2 d of treatment. Partial starvation of these cells 
under specified growth conditions does not affect the general growth pattern of 
the cells, general protein synthesis, and thymidine uptake, but does affect DNA 
synthesis. When cells are cultured under conditions in which DNA synthesis is 
preferentially inhibited, BrdUrd does not induce prolactin synthesis, suggestive of 
a  DNA-mediated mechanism of action for the drug. 
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The drug 5-bromodeoxyuridine (BrdUrd), a thy- 
midine analogue, seems to have diverse effects on 
the various processes of differentiation in eukar- 
yotic cells. These may be classified into two dis- 
tinct  types.  BrdUrd  suppresses  the  synthesis of 
specific proteins in certain cells, and in other cell 
types the drug induces the production of certain 
cell-specific proteins. Rutter et al. (12) described 
in detail the role of BrdUrd on  different eukar- 
yotic cell systems. On  the  basis of the  different 
effects of this drug,  these  authors  discussed the 
possible DNA-linked and non-DNA-linked mech- 
anisms of action of BrdUrd. 
Holtzer and Abbott (7) postulated that BrdUrd 
selectively inhibits the  synthesis of luxury mole- 
cules without  grossly depressing the synthesis of 
essential molecules of the cells. Priesler et al. (11) 
claimed that  inhibition of differentiated function 
J. CELL BIOLOGY ￿9  The Rockefeller University Press ￿9 0021-9525/79/04/0001/09  $1.00 
Volume 81  April 1979  001-009 is dependent upon incorporation of BrdUrd into 
DNA  whereas  induction of cell-specific protein 
synthesis  does  not  require  such  incorporation. 
Davidson and Kaufman (6), in their studies with 
Syrian hamster melanoma cells, demonstrate that 
BrdUrd  suppresses  pigment formation  in  these 
cells and that this suppression can be reversed by 
addition of deoxycytidine (dCyd) to  the  culture 
medium. The effect of dCyd on the suppression of 
pigmentation does not depend on the incorpora- 
tion of BrdUrd into DNA. In contrast, Stellwagen 
and Tomkins (14)  and O'Brien and Stellwagen 
(10) postulate that incorporation of BrdUrd into 
DNA is obligatory for its effect on the inhibition 
of synthesis of tyrosine aminotransferase in hepa- 
toma cells. 
We have reported previously (2) that BrdUrd 
induces prolactin synthesis in a clonal strain of rat 
pituitary tumor cells (GH,2C~), and in a substrain 
of GH~2C~ cells isolated by exposure of these cells 
to  30  /xg/ml  BrdUrd.  Prolactin synthesis in the 
BrdUrd resistant (BrdUr&) cells can be detected 
after 8-10 d of treatment with the drug (30 /~g/ 
ml). Previous results (2) demonstrate that uptake 
and incorporation of BrdUrd and thymidine into 
DNA  is  identical in the BrdUrd  sensitive (Brd- 
Urd  ~)  parent  strain  and  in  the  BrdUrd  r  strain. 
These  results  would  suggest  that  the  resistant 
phenotype of F~BGH~2C~ is not caused by a lesion 
in any of these steps leading to the incorporation 
of the drug into DNA. In this investigation, we 
deal with the mechanism of induction of prolactin 
synthesis by  BrdUrd  in  F~BGH~2C~ cells,  and 
present experimental evidence which is consistent 
with  a  DNA-mediated  mechanism  of  BrdUrd 
action on cellular differentiation. 
MATERIALS  AND  METHODS 
Materials 
Culture media and sera were obtained from Grand 
Island Biological  Co. (Grand Island, N. Y.), and culture 
dishes and flasks from Falcon Plastics (BBL Microbiol- 
ogy Systems, Becton, Dickinson & Co., Cockeysville, 
Md.).  BrdUrd,  thymidine,  dAMP,  dGMP,  dTMP, 
dCMP,  and  BrdUMP  were purchased from Sigma 
Chemical Co.  (St. Louis, Mo.).  [Methyl-aH]thymidine 
(20  Ci/mmol),  [6-3H]BrdUrd (23.6 Ci/mmol),  L-[U- 
14C]leucine (297 mCi/mmol), 32p as carrier-free ortho- 
phosphoric acid, and  Omnifluor were obtained  from 
New England Nuclear (Boston, Mass.). Rat prolactin 
was obtained from the Rat Pituitary Hormone Distribu- 
tion Program (National Institute of Arthritis, Metabo- 
lism, and  Digestive Diseases, National  Institutes  of 
Health)  and  polyethyleneimine (PEI)  cellulose sheets 
from Brinkmann Instruments, Inc. (Westbury, N. Y.). 
Methods 
Cells used  in  this investigation were rat  pituitary 
tumor cells in culture, designated as GH ceils. GH12C, 
is a clonal strain of GH cells. It produces large amounts 
of growth hormone but does not produce any detectable 
prolactin (for review, see reference 9). FtBGH~2C~ cells 
are  surviving populations  isolated by  exposure of 
GH~2C~ cells to  30  tzg/ml BrdUrd  (2).  Cells were 
maintained in Ham's F-10 medium supplemented with 
15% horse serum and 2.5% fetal calf serum. Growth 
conditions are described in greater detail in the legend to 
individual figures. Growth  of cells was  measured by 
determination of total  cell protein  by the  method of 
Lowry et al. (8). 
Prolactin in the growth medium of cell cultures was 
determined by microcomplement fixation immunoassay 
(15). The absolute sensitivity  of the method for prolactin 
is 3-5 ng. 
DNA synthesis in cells under different growth con-. 
ditions was determined by measurement of the incor- 
poration  of  [SH]thymidine (in  some  experiments 
[aH]BrdUrd) into trichloroacetic acid (TCA)-insoluble 
radioactivity after a 3-h pulse. Most of this (90-95%) 
TCA-insoluble radioactivity was solubilized upon prior 
treatment of the cell extracts with DNase 1 (2). 
Uptake of [3H]thymidine  or [SH]BrdUrd by the cells 
in different stages of DNA synthesis was determined by 
measuring intracellular TCA-soluble radioactivity.  TCA- 
soluble radioactivity  attained maximum levels within 10- 
15  min of exposure of  these cells to  the  radioactive 
precursors. 
Protein synthesis under specified growth conditions 
was measured by pulse-labeling  the cell with [~4C]leucine 
3 h before harvesting (see figure legends for details). 
Hot TCA-precipitable radioactivity was measured in an 
aliquot of cell-extract prepared as described in the figure 
legends. 
Base Analysis  of 3zP-Labeled DNA 
Cells were exposed to ~P (as carrier-free orthophos- 
phoric acid, 2 /~Ci/ml) for 48 h. Cells were harvested 
and  washed with Tris-buffered saline (TBS)  (4)  and 
stored at -80~  DNA from these cells was extracted by 
using the method described by Stellwagen and Tomkins 
(14)~ [~PJRNA was removed from the DNA prepara- 
tions by treatment with heat-treated pancreatic RNase 
A. The twice-precipitated DNA was pelleted by centrif- 
ugation at 10,000 g for 15 rain at 4~  The DNA was 
dissolved and dialyzed against buffers under the condi- 
tions described by Bick and Davidson (1). 
The dialyzed [szP]DNA solution was then hydrolyzed 
by sequential treatment with two enzymes, DNase 1 and 
snake venom phosphodiesterase under  the  conditions 
described by Bick and Davidson (1). The 5'-deoxymon- 
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DNA  were  then  concentrated  by  lyophilization  and 
extracted with  methanol  as  described  by Couch  and 
Hanawalt (5).  100- to 200-p.1 samples were then ana- 
lyzed by two-dimensional PEI cellulose chromatography 
by using the method described by Couch and Hanawalt 
(5).  For the identification  of the different  [a2P]deoxy- 
mononucleotides obtained after such hydrolysis of DNA, 
authentic samples of dAMP, dGMP, dCMP, dTMP, and 
BrdUMP were co-chromatographed  with the samples to 
be analyzed and identified  under ultraviolet  light. The 
location  of  the  well-separated  deoxymononucleotides 
was circled, and these areas of the cellulose plates were 
cut and counted in Omnilluor in a Packard Scintillation 
Counter  (Packard  Instrument  Co.,  Inc.,  Downers 
Grove, I11.). For autoradiographic  identification of ~P- 
labeled deoxymononucleotides,  the  dried plates were 
exposed to Kodak x-ray films (X-Omat R-film, XR-5) 
for  16-18  h  and  subsequently  developed. Authentic 
deoxymononucleotides,  as visualized  under  UV  light, 
and radioactive spots were superimposable. 
RESULTS 
Growth Characteristics  of and Prolactin 
Production by BrdUrd-Resistant 
FIBGH12C1 Cells 
The  results  presented  in  Fig.  1A  show  the 
growth  pattern  of  the  FaBGH12C~  cells  in  the 
presence  or absence  of BrdUrd.  The  growth of 
these  cells was  not  different  when  tested  after 
maintaining the  cells in the  absence of the  drug 
for  at  least  1  yr.  These  results suggest that  the 
cells are  not  drug  dependent  and  also  that  the 
resistant phenotype of these cells is a stable one. 
Though the subclone was isolated by selecting the 
survivors in the presence of 30 p,g/ml BrdUrd, the 
results  presented  in  Fig.  1A  demonstrate  that 
these cells could tolerate as much as 300/xg/ml of 
the drug in the growth medium. Prolactin produc- 
tion by FIBGH~2C1 cells in the presence of 30/zg/ 
ml and that by GHI2C~ cells in the presence of 3- 
5  /~g/ml of the drug could be detected after 8-10 
d  of exposure of the cells to the drug. However, 
results presented in Fig. 1 B  demonstrate that this 
long latent period of prolactin induction could be 
reduced  by  treatment  of  the  cells  with  higher 
concentrations  of  the  drug.  In  the  presence  of 
300,  120,  and  60  /zg/ml  of BrdUrd,  prolactin 
production  could be  detected at  1,  4,  and  7  d, 
respectively. 
While  prolactin  synthesis  in  these  cells  was 
induced, there was no detectable increase in the 
total  protein  or  DNA  synthesis  after  treatment 
with the drug. Total RNA synthesis in intact cells, 
and  RNA  synthesis  in  a  cell-free  system  with 
isolated nuclei (3), was the same in both control 
and treated cells. By comparing RNA synthesis in 
nuclei from  control and BrdUrd-treated cells, it 
was found that Km values for all four nucleoside 
triphosphates were unaltered after drug treatment 
(Kin =  3--4 ￿  10 -r M; unpublished data). Growth 
hormone,  which constitutes a  significant fraction 
of the  total  protein  synthesized by  F1BGH~2C1 
cells, is also unaffected by treatment with BrdUrd 
(2). 
Relationship of Prolactin Induction 
to DNA Synthesis 
The  BrdUrd  induction  of  prolactin  synthesis 
was  studied in  F1BGH~2C1  in  relation to  DNA 
synthesis in these cells. The main emphasis of the 
experimental approach was  to  preferentially in- 
hibit DNA synthesis without drastically affecting 
other cellular biochemical processes. The cellular 
processes which were monitored under these con- 
ditions are (a) general growth, (b) general protein 
synthesis,  (c)  [3H]thymidine  uptake,  (d)  DNA 
synthesis,  and  (e)  prolactin  synthesis.  The  two 
inhibitors of DNA  synthesis,  mitomycin  C  and 
cystosine arabinoside, at 0.05  /~g/ml and 2-5 /~g/ 
ml, respectively, inhibited protein synthesis within 
2-3 d of treatment of the cells with the drugs (data 
not shown).  Thus,  these inhibitors of DNA syn- 
thesis were found to be not suitable for this study. 
However,  experimental conditions which  would 
preferentially block  DNA  synthesis were  estab- 
lished by addition of limited amounts of growth 
medium to a specified number of cells (6-8 ￿  105 
cells/4 ml F-10 medium). Under these conditions 
(see legend to Fig. 2), DNA synthesis reached a 
maximum level within 3-4 d, and declined there- 
after  (Fig.  2A).  Protein  synthesis  under  these 
growth conditions was not affected and continued 
for at least 3-4  d  more, though at a  slower rate 
(Fig.  2A).  RNA  synthesis,  as  determined  by 
incorporation  of  [3H]adenosine  and  [3H]guano- 
sine  into  TCA-precipitable  material,  was  also 
found to be not affected and continued for 3-4 d 
more.  (Unpublished results, obtained by Dr. T. 
F.  J.  Martin,  Dept.  of Zoology,  University  of 
Wisconsin,  Madison,  Wis.,  by  growing  another 
clonal  strain  of  GH  cells under  similar growth 
conditions, i.e., 2  x  105  cells/ml F-10 medium). 
DNA synthesis resumed in these cells after a short 
lag period upon replenishment with fresh medium, 
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FIGURE 1  Growth and prolactin production by F~BGH12C1 cells at different concentrations of BrdUrd. 
FtBGH~2C1 cells were maintained in F-10 medium without BrdUrd for 12 mo before initiation of this 
experiment. Fig. 1A shows the growth of these cells in the presence of different amounts of BrdUrd (in 
/zg/ml), as indicated by the numbers with the arrows, and in absence of the drug (control). Cells were 
grown in 60-mm dishes and  scraped from  the  dish after  the  indicated days of treatment  with the 
appropriate amounts of the drug. Protein was determined in an aliquot of the cell extracts by the method 
of Lowry et al. (8). Each point represents the amount of protein averaged from duplicate dishes. Fig. 1  B 
shows the prolactin production by F1BGH~2C1 cells at different concentrations of BrdUrd. Prolactin in the 
medium of the cells was determined by complement fixation assay. Each point represents the amount of 
prolactin averaged from duplicate dishes. Numbers indicated by the arrows are concentrations of BrdUrd 
(in/zg/ml) in the growth medium. 
and  protein  synthesis  resumed  its  normal  rate 
after the medium change (Fig. 2A). 
The incorporation of [3H]BrdUrd into DNA in 
F~BGH12C~ follows the same pattern as the incor- 
poration of thymidine (2).  Furthermore, the  in- 
corporation of [3H]BrdUrd into TCA-soluble ra- 
dioactivity was not affected by limiting the growth 
medium, indicating that the uptake of BrdUrd by 
these  cells remains unaltered. Thus,  aside  from 
the  inhibition of DNA synthesis, no other gross 
effects  on  the  macromolecular synthesis and on 
the physiology of the cells could be detected under 
the conditions of cell culture. 
Under the defined growth conditions, prolactin 
synthesis in F~BGH12C~ cells followed the  same 
pattern  as  DNA  synthesis (Fig.  2B).  Prolactin 
synthesis was detectable within 1-2 d of growth of 
these cells in the presence of 300/zg/ml BrdUrd, 
reached a maximum in 3-4 d, and declined there- 
after in parallel with the decline of DNA synthe- 
sis.  Prolactin  synthesis  resumed  in  conjunction 
with DNA  synthesis after addition of fresh me- 
dium to the cells (Fig. 2B). 
The results presented in Fig. 3A show the level 
of DNA synthesis, and Fig. 3 B shows the BrdUrd 
induction of  prolactin  synthesis  in  FIBGH~2C1 
cells.  F1BGH~2C~ cells  were  grown  (under  the 
same conditions as described in the legend to Fig. 
2) initially in the absence of BrdUrd. Addition of 
BrdUrd (300  /xg/ml)  on the 4th d  of growth (as 
indicated by the arrow in Fig. 3) induced prolactin 
synthesis only in those cells  (Fig. 3B,  O--O) in 
which DNA synthesis (Fig. 3A, O--O) was per- 
mitted to continue. The cells that did not receive 
any  fresh  medium,  i.e.,  cells  in  which  DNA 
synthesis could  not continue (Fig.  3A,  O--O), 
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did not produce any detectable prolactin (Fig. 3 B, 
O---@) even in the presence of BrdUrd (added on 
the 4th d as indicated by the arrow). The cells that 
received fresh medium on the 4th d of growth, in 
!  I  I  I 
2  4  6  8 
DAYS 
the absence of BrdUrd, also did not produce any 
detectable prolactin  (Fig. 3 B, &--&). These re- 
suits demonstrate that there is a parallel relation- 
ship between DNA synthesis and BrdUrd induc- 
tion  of prolactin  synthesis  in  these  cells,  under 
these defined growth conditions. 
Base Composition of DNA Isolated from 
Control and BrdUrd- Treated Cells 
Base  composition  of the  DNA  isolated  from 
control and BrdUrd-treated cells was determined, 
and  the  results  are  presented  in  Table  I.  It  is 
evident  from these  results  that  BrdUMP,  desig- 
nated  by letter  B,  was  absent  in  DNA  isolated 
from  control  cells.  BrdUMP  in  DNA  isolated 
from BrdUrd-treated  cells  (300  /zg/ml  for 2  d) 
constituted as much as 26% of the total bases with 
concomitant  reduction  in  the  amount  of dTMP 
(designated  by  the  letter  T).  The  amount  of 
FmURE  2  Effect of growth of cells in limited medium 
on DNA, protein, and prolactin synthesis in F~BGH12C1 
cells.  6-8  ￿  l0  s  cells were  plated  in  100-mm  dishes 
containing only 4  ml  of  F  10  medium.  BrdUrd  was 
added  to  the  final concentration of 300  /xg/ml.  Cells 
were  pulsed  with  [aH]thymidine  (5  /zCi/ml)  and with 
[14C]leucine  (20  /zCi/ml) 3  h  before harvesting on the 
specified  day  and  incubated in  the  humidified atmos- 
phere of 5% CO2 and 95% air at 37~  Cells were then 
harvested  after  this  period,  washed  with  TBS  three 
times, and resuspended in 1 ml of TBS. Cells were lysed 
by addition of 0.05 ml of 2 % SDS, and the radioactivity 
in an aliquot was measured after precipitation with 2 ml 
of  10%  TCA.  Both  ZH-  and  ~4C-radioaetivity  were 
determined in each sample. About 90-95 % of the TCA- 
insoluble  all-radioactivity  became  TCA  soluble  upon 
prior treatment of the cell extracts with DNase 1 under 
conditions described  previously.  Prolactin,  in the  me- 
dium withdrawn on the specified day, was determined 
by microcomplement fixation assay. At the arrow, me- 
dium was removed and fresh medium (4 ml) was added. 
Fig.  2A  shows  the  [aH]thymidine  incorporation  into 
DNA (O---@) and  [~4C]leueine incorporation into pro- 
tein (O---￿9  as determined by TCA-insoluble all- and 
~4C-radioactivity  in aliquots of extracts of cells harvested 
on  the  specified  day.  Dashed  lines  represent 
[SH]thymidine and  [~4C]leucine incorporations after re- 
plenishment with the fresh medium on the day indicated 
by the arrow. Each point represents average radioactiv- 
ity in extracts of cells prepared from duplicate dishes. 
Fig. 2 B shows the amount of prolactin produced by cells 
on the indicated day. Each point represents the amount 
of  prolactin  in  the  medium  averaged  from  duplicate 
dishes. The arrow indicates the day of addition of fresh 
medium (4 ml). 
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letters G, C,  and A, respectively, seemed to be 
unaltered in the DNA isolated from control and 
BrdUrd-treated cells. These results demonstrate 
that treatment of the cells with increasing amounts 
of  the  drug  for  the  periods  (days)  indicated in 
parentheses caused increased replacement of thy- 
midine. Treatment of the  cells with the  drug at 
any concentration did not alter the  G, C,  or A 
content of the DNA. The total B  and T content 
was  equivalent to  the A  content of  the  DNA 
isolated from treated cells with each concentration 
of BrdUrd.  These  results show  that B  replaces 
only T of the DNA in the treated cells. 
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Relationship between BrdUrd Replacement 
of Thymidine in DNA and 
Prolactin Synthesis 
The  results  presented  in  Fig.  4A  show  the 
percent  replacement  of  thymidine  in  DNA  by 
BrdUrd and prolactin production by FIBGHa2C1 
cells at different concentrations  of the drug. Treat- 
ment of the cells with increasing concentrations of 
BrdUrd (ranging from 30 to 300 p,g/ml)  led to a 
concentration-dependent increased  replacement 
(O--O) of thymidine in the DNA by the drug. As 
BrdUrd concentration was raised, the increase in 
thymidine replacement of the drug paralleled the 
increase in prolactin found in the culture medium 
(0--0).  Similarly, the  results presented in Fig. 
4B  demonstrate  that  when  the  drug  was  with- 
drawn,  prolactin production declined in parallel 
with the reduction of the level of thymidine substi- 
tution by BrdUrd. 
Fig.  5  shows  the  early  and  late  kinetics  of 
induction of prolactin synthesis (O--O) in relation 
to altered base composition of the DNA (O----O). 
BrdUrd (300/xg/ml), when added to FIBGH12C1 
cells  grown  under  the  conditions which  permit 
continued DNA synthesis, replaced thymidine in 
the DNA to the extent of 5 % after 6 h. However, 
no prolactin could be detected in the medium of 
these cells (Fig. 5). BrdUrd substitution for thy- 
midine in the DNA of treated cells continued to 
increase with time and reached -75%  after 2 d. 
FIGURE 3  Relationship between BrdUrd  induction of 
prolactin synthesis and DNA synthesis. F1BGH12C1 cells 
were plated at 6-8 x 105 cells/100-mm  dish with 4 ml of 
F-10 medium in the absence of BrdUrd.  Three sets of 
such dishes in duplicates were used in this experiment. 
Fig. 3A  shows the levels of DNA synthesis in cells as 
determined by pulsing the cells with [aH]thymidine 3 h 
before withdrawal of the medium and harvesting of the 
cells on the specified day. TCA-insoluble radioactivity 
was determined as described in the legend to Fig. 2. Fig. 
3B  shows the  prolactin production by  these cells as 
determined after assay of cell medium by microcomple- 
ment fixation. From one set of dishes (O--O) medium 
was removed and saved for prolactin determination and, 
to this set of dishes, fresh medium (4 ml) and BrdUrd 
(300 /xg/ml) were added  on the  4th  d  of growth as 
indicated by the arrow. The second set of dishes (O----O) 
received only BrdUrd  (300 ttg/ml), and the cells were 
maintained  without  medium  replacement.  From  the 
third set of dishes (A--A, Fig. 3 B only) medium was 
removed and 4 ml of fresh medium was added. The third 
set of dishes did not receive any BrdUrd. 
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Base Composition of DNA Isolated from Control and BrdUrd-Treated Cells 
BrdUrd  G  C  A  T  B  [B-+~] 
l~g/ml  % 
None  18.1  19.8  32.0  30.1  -  -- 
30 (9)  19.1  19.8  31.0  24.0  6.2  20 
60 (8)  18.6  19.3  31.3  22.8  8.0  26 
120 (5)  18.2  20.6  31.3  17.6  12.0  40 
300 (3)  18.5  18.8  31.1  5.8  26.1  81 
F~BGH~2C1 cells were  grown  in  F-10  medium  in  100-mm  dishes  in  the  presence  of BrdUrd at the  indicated 
concentrations.  Medium was changed  every 3 d. Cells were  pulsed with 32p for 48  h and harvested  on the days 
indicated  in  parentheses.  [~P]DNA was  isolated  from  these  cells and  hydrolyzed  enzymatically to  a2P-labeled 
deoxymononucleotides.  These were subsequently separated by two-dimensional PEI-cellulose chromatography. The 
radioactivity in each spot was determined as described in Materials and Methods. 
Substitution of thymidine by BrdUrd in DNA did 
not reach >82%  even after continued treatment 
of the cells with 300/~g/ml of the drug for as long 
as 8-10 d. Prolactin (Fig. 5, O--O) in the medium 
of the cells could not be detected at 6, 12, and 16 
h of treatment, times at which thymidine replace- 
ment was 5,  12,  and  18%,  respectively (Fig. 5, 
0--0).  However,  prolactin  could  be  detected 
(Fig.  5,  O--O)  after  treatment  for  24  h  when 
thymidine replacement was  -25%.  In some ex- 
periments, prolactin production could be detected 
at the base substitution level as low as 20%. 
The results presented in Fig. 4A and B  and Fig. 
5 suggest that BrdUrd induction of prolactin syn- 
thesis in FIBGH12C~ cells is mediated via incor- 
poration of the drug into DNA, and also demon- 
strates  a  parallel relationship between  prolactin 
production and the extent of thymidine substitu- 
tion by BrdUrd. The results presented in Table II 
show that detectable prolactin synthesis occurred 
in  GH-cell  strain  GH12C~  after  treatment  with 
BrdUrd for 9  d  at 5  /xg/ml, in FIBGH~2C~ cells 
after 9 d at 30/zg/ml, and after 1 d at 300/xg/ml. 
In  all  cases,  when  prolactin  synthesis  was  first 
detected,  replacement  of thymidine by  BrdUrd 
was comparable and found to be in the order of 
22-25 %. 
DISCUSSION 
We have reported previously that BrdUrd induces 
prolactin synthesis in GH~2CI,  a  clonal strain of 
rat  pituitary tumor  cells,  and  in  FIBGH~2C~,  a 
subclone of GH~2C1  (2). While prolactin synthesis 
in these cells was induced, there was no detectable 
increase  in  the  total  protein  or  DNA  synthesis 
after treatment with  the  drug.  The  induction of 
prolactin synthesis in F1BGH~2C~ cells occurs only 
in  the  presence of BrdUrd with  a  concentration 
dependent  lag  period  (Fig.  1B).  An  important 
property of these cells is that they can be grown in 
the presence of higher concentrations of the drug 
(300/zg/ml), which reduces the lag period for the 
induction of detectable prolactin synthesis to 24 
h. This permits us to study the induction phenom- 
enon  in  relation  to  DNA  synthesis  in  greater 
detail.  Culturing  cells  in  a  limited  amount  of 
medium  (2  ￿  l0  s cells/ml of medium) does not 
seem  to  affect  their  growth,  protein  synthesis, 
RNA synthesis, or thymidine uptake until after 6- 
7  d.  However,  FIBGH12C1  cells cannot  reenter 
the "S" phase (DNA synthesis phase) of the cell 
cycle after growth  in  limited medium  for 3-4  d 
(Fig. 2A), whereas total protein synthesis, in the 
absence of DNA synthesis, continues for at least 
3-4  additional d. Thus,  studies on  the induction 
of prolactin synthesis have been undertaken dur- 
ing the  period (6-7  d  in  limited medium) when 
none of the major cellular processes, except DNA 
synthesis, are affected grossly. It is still possible, 
though unlikely, that  there are minor non-DNA 
effects on cellular metabolism which do not affect 
general protein synthesis but affect synthesis of a 
specific  protein,  e.g.,  prolactin.  However,  our 
results  suggest  that  prolactin  synthesis  can  be 
induced  only  when  BrdUrd  is  added  to  cells 
during the "S" phase of the cell's growth cycle or 
when  the  cells  are  permitted  to  enter  the  "S" 
phase  (Figs.  2B  and  3B),  but  not  when  DNA 
synthesis is arrested (Fig. 3 B). 
BrdUrd is incorporated into DNA, substituting 
for its structural analogue thymidine to the extent 
of  80%  without  affecting  the  content  of other 
bases (Table  I). This raises the  question:  Is the 
altered  DNA  structure  which  results  from  base 
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induction  of  prolactin  synthesis  in  these  cells? 
Prolactin  synthesis  increases  linearly  in  parallel 
with  the  increasing  thymidine  substitution  by 
BrdUrd  in  the  DNA  of these  drug-treated  cells. 
Similarly,  when  the  drug  is withdrawn  from  the 
cells  after  maximum  base  substitution  (80%), 
prolactin  synthesis  declines  in  parallel  with  the 
reduction  in  the  substituted  base  (Fig.  4).  This 
parallel relationship between base substitution and 
prolactin synthesis suggests that the incorporation 
of  the  drug  into  DNA  may  be  involved in  the 
induction process. Initiation of prolactin synthesis 
appears  to be dependent  on a  minimum  amount 
(20-25 %) of thymidine substitution by B rdUrd in 
DNA  (Fig.  5  and  Table  II),  which  suggests  that 
the event that triggers BrdUrd induction of prolac- 
tin synthesis is also related to a  critical alteration 
in the DNA  structure,  However, these results do 
not  completely  rule  out  the  possibility  that  the 
assay for prolactin used in this investigation is not 
sensitive enough to detect a very small amount of 
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F~GURE  5  Kinetics of prolactin induction. F~BGH~2C~ 
cells  were grown under the conditions as described in 
the legend to Fig. 2. Medium was replaced every 3 d. 
Cells were pulsed with a=P 48 h before harvesting on the 
specified  days of drug treatment (300/zg/ml). Prolactin 
in the medium and percent replacement of thymidine by 
BrdUrd in the DNA of these cells were determined as 
described earlier. 
PIGURE 4  Relationship between base substitution  and 
prolactin synthesis.  F]BGH12C1 cells were grown under 
the conditions described in the legend to Fig. 2. Fig. 4A 
shows prolactin production (O---Q) and percent thymi- 
dine  replacement  of BrdUrd  (O--O)  in  the  DNA of 
cells grown in the presence of different concentrations of 
the drug. The cells were grown in the presence of 30, 
60,120, and 300/zg/ml of BrdUrd for 9, 7, 5, and 3 d, 
respectively. Cells were pulsed with a2p (5 txCi/ml) 48 h 
before harvesting on the specified  day. Prolactin in the 
medium  was  measured  by  microcomplement  fixation 
assay,  and 32P-labeled DNA was isolated and analyzed 
for determination of percent replacement of thymidine 
by BrdUrd as described in Materials and Methods. Fig. 
4 B shows the effect of withdrawal of BrdUrd on prolac- 
tin  production  (O--Q)  and  percent  replacement  of 
thymidine by BrdUrd in the DNA (O--O) of cells after 
prior drug treatment. FIBGH12C~ cells were grown in F- 
10 medium under the conditions described above in the 
presence of BrdUrd (300  /.~g/ml) for 6 d. Medium was 
removed on this day for the determination of prolactin, 
a2P-labeled DNA was isolated from cells, and the percent 
replacement of thymidine by BrdUrd was determined. 
Separate  sets  of  dishes  containing  drug-treated  cells 
received fresh medium. The cells were then grown in the 
absence of the drug and harvested on the indicated days 
after withdrawal of the drug. Prolactin  in  the medium 
and percent replacement of thymidine by BrdUrd in the 
DNA of the cells  were determined  in  each sample  as 
described above. 
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Replacement of Thymidine by BrdUrd in DNA, 
and Initiation of Prolactin Synthesis 
Exposure  % replace-  Prolactin 
BrdUrd  Strain  to drug  ment*  production 
I.~g/ml  d 
5  GH12C~  9  25  + 
30  FtBGH~2Ct  9  23  + 
300  FtBGH12C1  1  22  + 
GHt2C1  and FIBGHt2C1  cells were grown in the pres- 
ence  of  different  concentrations  of  BrdUrd  for  the 
indicated period of time under the conditions described 
in Table I. Cells were pulsed with asp for 48 h. [~2P]DNA 
was isolated, and the base composition of the DNA was 
determined by using the procedure described in Materi- 
als and Methods. Prolactin in the medium withdrawn on 
the specified day was determined by microcomplement 
fixation assay. 
prolactin  synthesis  initiated  at  base  substitution 
<20%.  Though thymidine substitution by BrdUrd 
reaches  a  maximum  of  80%  within  2  d  and 
remains  at this level beyond  this period  of treat- 
ment  (Fig,  5),  prolactin  synthesis  continues  to 
increase even after 2  d  but at a  much slower rate. 
It is possible that once the maximum  alteration in 
the DNA  structure caused by base substitution is 
achieved  and  maintained,  prolactin  gene  expres- 
sion is turned on and continues to be at this stage 
of expression even when no further base substitu- 
tion occurs. 
These  results demonstrate  that  BrdUrd  induc- 
tion of prolactin synthesis maintains a  strict paral- 
lel  relationship  with  (a)  DNA  synthesis, and  (b) 
BrdUrd  incorporation and base substitution in the 
DNA,  Thus,  these results are  in  agreement  with 
DNA-linked  mechanisms  of action of BrdUrd  on 
the control of differentiated function proposed  by 
Rutter  et  al.  (12).  It  may  be  postulated  that 
BrdUrd  substitution  of  thymidine  in  the  DNA 
causes sufficient alteration  in  the structure of the 
genome  leading to  altered binding affinity for the 
cellular  regulatory  molecules  to  DNA.  Thus,  an 
increase  in  the  affinity of binding to  DNA  of an 
"activator"  or decrease in the same for a  "repres- 
sor" type  of molecule  will  lead  to  the expression 
of a  specific  gene  which  is  normally  suppressed. 
However,  such  a  model  does  not  explain  the 
results obtained  by  other  investigators  (6,  13)  in 
different  systems  in  which  incorporation  of 
BrdUrd  into DNA  does not seem to be obligatory 
for its action.  In these systems, it is possible that 
BrdUrd  acts  via  a  mechanism  that  is  different 
from the one described above, or it is also possible 
that,  in these systems, BrdUrd  acts via a  mecha- 
nism  which  demands  only  very  low  levels  of 
incorporation  of the  drug  and  thus undetectable 
substitution for thymidine in the DNA.  The pres- 
ent  study  provides  means  to  identify  the  regula- 
tory molecules that are involved in the suppression 
of  a  specific  gene  such as  the  prolactin  gene  in 
GHt2Ct  ceils and also helps in understanding  the 
mechanism  involved  in  the  effect  of BrdUrd  on 
the control of gene expression. 
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